OTIC(SZ:000962) Zheng Quan Zhi Xing·2025-08-25 17:27Fundraising Overview - The company raised a total of RMB 674,627,088.84 through the issuance of 59,281,818 shares at a price of RMB 11.38 per share, with net proceeds amounting to RMB 670,204,385.22 after deducting underwriting fees and other expenses [1][2] - The funds were received on September 27, 2023, and verified by an accounting firm [1] Fund Usage and Balance - As of June 30, 2025, the company has utilized RMB 543,095,579.78 of the raised funds, leaving a balance of RMB 128,104,683.89 in the special account [2][3] - The difference of RMB 995,878.45 between the utilized amount and the net proceeds is attributed to interest income minus bank fees [2] Fund Management - The company has established a dedicated management system for the raised funds, adhering to relevant regulations and guidelines [2][3] - A special bank account has been opened solely for the storage and use of the raised funds, with a tripartite supervision agreement signed with banks and the sponsor [3] Project Investment Status - No changes have occurred in the investment projects funded by the raised capital during the reporting period [5] - The company has reported that the investment projects are progressing as planned, with specific projects such as the tantalum-niobium metallurgy product line and the niobium superconducting cavity production line undergoing technical upgrades [7][8] Financial Performance of Projects - As of June 30, 2025, the investment progress for the niobium superconducting cavity production line is at 65.01%, with reasons for delays including pre-investment using self-raised funds and cost management strategies [7][8] - The company has not encountered any significant changes in project feasibility or major issues regarding the use and disclosure of raised funds [8]